The lower urinary tract has been traditionally considered to be a sterile environment, in which the presence of bac teria, revealed by culturing, is indicative of an infection. However, findings from studies over the past 8 years indi cate that urine is actually not free of bacteria and other microorganisms under healthy conditions [1] [2] [3] [4] [5] [6] [7] [8] . Rather, the urinary tract harbours its own microbial community that is collectively referred to as the urinary microbiota. These studies have sampled catheter-collected urine and clean-catch midstream urine to capture both the urinary microbiota and combined genitourinary microbiota (Box 1), respectively, and have identified a number of uri nary bacteria that cannot be detected by traditional clin ical microbiology techniques but that can be detected using 16S ribosomal RNA (rRNA) gene sequencing 2, 5 and expanded culture techniques 3, 4, 9 . Understanding the composition of normal micro bial communities in the lower urinary tract of healthy individuals will be essential to elucidate the microbial changes associated with abnormal lower urinary tract symptoms. In women, the urinary and genitourinary microbiota have been found to be altered in a variety of disorders, such as overactive bladder syndrome (OAB) 10 , urgency urinary incontinence (UUI) 4, 5, 11 and interstitial cystitis/bladder pain syndrome (IC/BPS) 8, 12 . Similarly, in men, the genitourinary microbiota seem to be altered in men with sexually transmitted infections 13 , prostatitis 14 , chronic pelvic pain 15, 16 and prostate cancer 17 . Together, these studies provide strong evidence that the urinary and genitourinary microbiota are associated with alter ations in lower urinary tract symptoms and warrant further investigation.
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In other regions of the body, such as the gut and vagina, resident microorganisms have a key role in main taining homeostasis, and dysbiosis of these communities has been linked to disease 18, 19 . Modulating these micro bial communities through the use of probiotics, pre biotics or microbiota transplants has been explored as a therapeutic strategy for a variety of human diseases 20 . Similarly, mapping the healthy urinary microbiota in healthy individuals and identifying the alterations in microbial composition that occur during bladder dis orders might radically transform how we treat bladder disorders 21, 22 . For example, findings from gut microbiota
Microbiota
The microorganisms (bacteria, archaea, fungi and viruses) present in a defined environment.
Catheter-collected urine
Urine collected via the insertion of a catheter into the urethra to directly collect urine from the bladder.
Clean-catch midstream urine
Voided urine collected by instructing individuals to clean the urethral area with disinfectant wipes, begin to void and then place a specimen cup into the urinary stream to collect urine. Abstract | Many studies have shown that the urinary tract harbours its own microbial community known as the urinary microbiota, which have been implicated in urinary tract disorders. This observation contradicts the long-held notion that urine is a sterile biofluid in the absence of acute infection of the urinary tract. In light of this new discovery , many basic questions that are crucial for understanding the role of the urinary microbiota in human health and disease remain unanswered. Given that the urinary microbiota is an emerging area of study , optimized techniques and protocols to identify microorganisms in the urinary tract are still being established. However, the low microbial biomass and close proximity to higher microbial biomass environments (for example, the vagina) present distinct methodological challenges for microbial community profiling of the urinary microbiota. A clear understanding of the unique technical considerations for obtaining and analysing low microbial biomass samples, as well the influence of key elements of experimental design and computational analysis on downstream interpretation, will improve our ability to interpret and compare results across methods and studies and is relevant for studies profiling the urinary microbiota and other sites of low microbial abundance. studies suggest that the overuse, prolonged use or incor rect use of antibiotics alter microbial composition, predisposing the host to colonization by pathogenic bac teria such as Clostridioides difficile (formerly Clostridium difficile) [23] [24] [25] . A similar level of evidence does not yet exist for the urinary microbiota literature, but a similar phe nomenon might conceivably occur and could explain why treatment with antibiotics for asymptomatic bac teriuria markedly increases the risk of recurrent UTI in young women 26 . The treatment of acute and recurrent UTI with oral and parenteral antibiotics could reduce the presence of beneficial bacteria that inhibit the growth of pathogenic bacteria. Accordingly, an understanding of the normal urinary microbiota could change our treat ment approach to bladder disorders such that we focus more on rebuilding a resilient microbiome to minimize host susceptibility to pathogenic bacteria rather than emphasizing the destruction of pathogenic bacteria with antibiotics, which inevitably induces damage to normal microbiota 27 . Given that the study of urinary microbiota is an emerging field, optimal techniques to identify the microorganisms in the urinary tract, bladder and other sites of microbial scarcity that were previously thought to be sterile (such as the lung and placenta) are not yet established. Importantly, the urinary tract seems to harbour a relatively small amount of bacteria (<10 5 colonyforming units per millilitre) 3, 4 compared with other body sites such as the vagina and gut (for example, faecal samples reflective of the gut microbiota typically have a bacterial abundance of ~10 11 bacteria per gram 28 ). Thus, techniques for sample collection and data analy sis need to account for issues that might arise owing to the low microbial biomass environment of the bladder and urinary tract, such as contamination introduced through sample collection and processing. A consistent and highyield analysis pipeline is required to inform the appropriate design of studies that seek to optimize the quality of their biological conclusions.
This Review provides a general overview of the methodology that is currently used to study the human microbiota and their collective genomes (known as the microbiome) and discusses elements of experimental design and data analysis that can have a large influence on studies of the urinary microbiota (Fig. 1 ). This infor mation will be useful for researchers studying the urinary microbiota as well as other sites of low microbial abun dance. Specifically, we discuss considerations for sample collection, laboratory methods for the identification of microbial communities, sources of contamination and approaches to control for them, computational consid erations for data processing and analysis and the scope and limitations of sequencingbased microbiome studies.
Considerations for sample collection
Bacteria isolated from voided urine are considered to be a reflection of the microbiota that reside in the bladder, urethra and surrounding external genitalia, whereas urine isolated directly from the bladder via transurethral catheterization is reflective of the bladder microbiota (Box 1). Although urine is fairly easy to collect, careful considerations must be made to minimize sample con tamination and to maximize the microbial information that can be obtained from these samples. In addition, to minimize unintended variability, efforts should be made to collect specimens in a standardized manner through out a study. Once collected, samples should be stored and transported under bacteriostatic conditions. Indeed, sample handling conditions are likely to profoundly influence the composition of a microbial community in a sample compared with that of its normal human envi ronment. For example, oxygen exposure can promote the propagation of aerobes but can induce cell death in strict anaerobes within minutes 29 . Thus, variables such as temperature, pH and oxygen tension should be con trolled and standardized throughout sample collection and processing. To minimize contamination, samples should ideally be processed in a biosafety cabinet after specimen collection. Other important considerations for sample collection include the specimen collection method, the volume used and the storage method in addition to the collection of comprehensive metadata about the specimens (Fig. 1) .
Sample collection method
When designing an experiment, investigators should carefully weigh the benefits and drawbacks of each sampling method and determine whether the cho sen sampling method will appropriately address the
Key points
• Similar to other areas of the human body, the urinary tract and bladder are inhabited by commensal microorganisms that are collectively referred to as the urinary microbiota.
• The composition of the urinary microbiota has been associated with response to treatments, risk of infection and urological disorders.
• Studying the urinary microbiota presents many challenges owing to its low microbial biomass and proximity to other body sites with rich microbial environments (such as the vulva and vagina).
• Further research to understand these microbial communities and their relationship with urological disorders is warranted and will require careful sample collection and data analysis to draw robust and reproducible conclusions.
• DNA sequencing techniques enable the culture-independent identification of bacteria but have limitations such as poor taxonomic resolution, inability to distinguish between living and dead bacteria and lack of functional annotation.
• Despite outstanding advances in microbiome bioinformatics that have improved the information gained from 16S ribosomal RNA gene sequencing studies, adoption of these methods is still lagging.
scientific question under investigation. Methods for collecting urine specimens directly from the bladder include suprapubic aspiration and transurethral catheter ization. To investigate the genitourinary microbiota of the lower urinary tract and surrounding genital areas, cleancatch midstream (voided) urine specimens can be used. Suprapubic aspiration is the cleanest method of urine collection and has a minimal risk of contami nation 1 . Risks associated with this collection method include pain associated with the use of a needle and the possibility of the needle traversing intestinal con tents 30 . Thus, collecting urine in this way for research or clinical purposes might not be practical owing to the invasiveness and risks of the procedure. Collecting urine using a transurethral catheter is less invasive than suprapubic aspiration, and the bacterial communi ties identified using this sampling method have been shown to be consistent with those of samples collected by suprapubic aspiration in women 1 . Risks associated with this collection method include urethral irritation and discomfort, both during and following catheteri zation, as well as a small risk of UTI 31 . Despite these risks, transurethral catheterization is generally well tolerated and has minimal adverse effects in the clinical research setting.
Obtaining a cleancatch midstream urine specimen is the least invasive and easiest method of obtaining urine from research participants; however, this method ena bles characterization of only the genitourinary micro biota, including those found in the lower urinary tract and genital regions, but not explicitly those found in the bladder. Owing to anatomical differences, urine collec tion from men and women presents different issues that must be considered to minimize contamination. One challenge with collecting cleancatch midstream urine specimens from women is potential microbial contami nation from the surrounding vulvovaginal region, which has its own microbial environment. Indeed, one study demonstrated that the bacterial profiles of cleancatch midstream urine specimens from each participant were more similar to each participant's vaginal bacterial pro file than to the bacterial profile of a urine specimen collected using suprapubic aspiration 1 . Approaches that have been used to minimize vulvovaginal contamination of cleancatch midstream urine samples from women include clean catch with labial separation under the supervision of a trained nurse 6, 8 . However, studies that have used this approach did not compare the urinary microbiota profiles obtained with those of vulvar, vag inal or cathetercollected specimens; thus, the success of this technique at minimizing vulvovaginal micro biota contamination is unknown. In general, obtaining a cleancatch midstream urine specimen that is free of microbiota from the vulvovaginal area is difficult. The identification and computational removal of the micro biota profile from the vulva and/or vaginal microbiome might be possible before downstream analysis, but no standard analytical approaches for this method cur rently exist. If such an approach was successfully devel oped, voided urine would provide a means to identify bacteria from the lower urinary tract with minimal contamination from surrounding tissues.
Urine specimens from men have a lower risk of con tamination from surrounding tissues than those from women. To date, studies of the male urinary microbiota have primarily used cleancatch midstream voided urine specimens 13, 32, 33 . However, whether or not the male ure thra has a microbial environment that is different from that of the urinary bladder is currently unknown. The male urinary microbiota profile (collected from voided specimens) has been found to be distinct from that of the microbiota inhabiting the coronal sulcus 33 but similar to that of the microbiota identified from urethral swabs 13, 32 . Thus, the microbiome in the bladders of men, similar to that of women, is probably distinct, and future studies should be designed to determine whether the bladder microbiome contributes to lower urinary tract disorders in men.
Sample volume
Another consideration when collecting samples is the amount of urine that is needed to extract a sufficient quantity of bacterial DNA. One key factor is the use of voided versus cathetercollected urine, given that cathetercollected urine will contain a lower abundance of bacteria. Studies have had high success rates (>85%) for identifying bacteria from voided urine samples of only 1-2 ml (reF. 34 ). However, studies investigating the bladder microbiome using cathetercollected urine samples of 1-2 ml could extract bacterial DNA from only ~50% of samples 1, 5, 35 . By increasing the amount of urine collected to 30-50 ml, one study reported the successful extraction of bacterial DNA from almost all (95%) of the cathetercollected urine samples 11 . Thus, given that cathetercollected urine has a low micro bial biomass, extracting and amplifying bacterial DNA from large sample volumes will probably be the most successful approach. Although the ideal urine sample volume needed to achieve a high yield of bacterial DNA is yet to be determined, we recommend a quantity of 30-50 ml, particularly for cathetercollected urine spec imens, which has proved successful for studies of the bladder urinary 11 and genitourinary 6, 8 microbiota; how ever, 1-2 ml specimens have been successfully used for voided specimens. Box 1 | Terminology for studying the microbiota of the urinary tract one challenge in emerging fields is ensuring that terminology is clearly defined. Studies investigating the urinary microbiota have not been consistent in the terminology used to specify which region of the urinary tract has been studied, which leads to confusion in the literature, particularly when making comparisons across studies. Authors should clearly define the sampling method used (such as clean-catch midstream-collected urine or catheter-collected urine) and the microbial niche that was studied. The bladder microbiota can be studied only with the use of catheter-collected or suprapubic aspirate-collected urine. Given that voided urine specimens will contain microorganisms from the bladder, distal urethra and potentially the surrounding genital regions (such as the vulva and vagina in women), we propose the term 'genitourinary microbiota' to describe voided specimens. Readers should be mindful of the sampling method used in order to place a study's findings in the appropriate context, particularly when comparing results across studies. In this Review, we used the term 'urinary microbiome' to discuss studies using catheter-collected urine and the term 'genitourinary microbiome' for studies using voided specimens.
Suprapubic aspiration
A procedure during which a needle is used to puncture the skin and abdomen to aspirate urine directly from the bladder.
Sample storage Specimens for sequencing should be aliquoted and frozen as soon as possible after collection to enable the subsequent parallel processing of multiple samples, which minimizes untraceable batch effects that can occur during sample processing. To date, no studies have examined the effect of sample handling and storage conditions on the downstream analysis of the urinary microbiota. Thus, no definitive guidelines for sample handling and storage currently exist. However, exten sive research regarding the influence of storage condi tions on the microbial composition of samples from other body sites has been conducted. Sample storage at −20 °C and −80 °C did not have a major influence on the microbial composition of vaginal 36 , skin 37 . However, whether these find ings translate to urine specimens is currently unknown, and we recommend storage of urine samples at −80 °C as soon as possible and consistency in the storage of all samples in a microbiome study.
Sample metadata
The human microbiome is dynamic and highly influ enced by the host environment. Indeed, dietary changes 39 , ageing 40 and lifestyle 41 , among other factors, have been found to influence the microbial composition of the gut. Furthermore, sexual activity and the menstrual cycle have been associated with changes in the compo sition of the vaginal microbiome 42 . Such variations in the urinary microbiome are currently understudied, but compositional differences that covary with age and sex have been identified in the genitourinary microbiome Conducting a urinary microbiome study requires many considerations in experimental design and data analysis. a | Sampling collection considerations include the sample collection method (voided versus catheter-collected urine), the use of a sufficient volume for the proposed study aims, sample storage (ideally at −80 °C) and the collection of metadata such as potentially confounding variables (for example, age, gender, BMI and medications). b | Sample preparation and DNA extraction considerations include using the same kits and reagents for all samples in a study , primer and hypervariable region selection, sequencing platform, adequate positive and negative controls to assess the success of the experimental and bioinformatics protocols and collection of metadata such as the kit lot numbers and laboratory personnel handling the specimens. c | Data processing and analysis considerations include the use of a workflow package such as Quantitative Insights Into Microbial Ecology (QIIME) or mothur for processing raw reads, filtering low-quality reads and removing chimeric sequences, operational taxonomic unit (OTU) or amplicon sequence variant (ASV) clustering algorithms for grouping similar reads together, a taxonomy assignment algorithm and database, evaluation of negative and positive controls and exploratory analysis for identifying experimental problems or confounding variables. Finally , data analysis to address the clinical question should include measures to control for covariates and adjust for multiple comparisons. rRNA , ribosomal RNA.
they might influence the composition or function of the urinary microbiota. In addition, detailed information about sample collection, such as time of day and study staff involved in sample collection and handling, should be recorded. These additional metadata can be used for exploratory data analysis to identify unanticipated rela tionships between these variables and the composition of the microbiota (such as batch effects), which might need to be controlled for in the later analyses.
Detection of microbial communities
Once samples have been collected, a variety of comple mentary methods can be used to identify the microbial composition of a sample, including DNA sequencing based methods in addition to conventional culture based methods. Whole-genome shotgun sequencing (shotgun metagenomics) aims to sequence all of the microbial genomic DNA in a given sample, whereas marker gene sequencing aims to sequence a specific microbial gene region. A commonly used marker gene is the 16S rRNA gene that is specific to bacteria and archaea, although additional marker genes for eukary otic microorganisms also exist (such as the 18S rRNA gene, the 28S rRNA gene and the internal transcribed spacer (ITS) for fungi) 43 . The 16S rRNA gene is a highly conserved gene that exists in all bacteria and archaea and has been used to study bacterial phylogeny since the late 1970s 44, 45 . These studies have led to a major shift in how scien tists classify microorganisms -from phenotypic classification (for example, Grampositive bacteria) to taxonomic classification into various kingdoms, phyla, classes, orders, families, genera and species. The 16S rRNA gene is ~1,550 bp in length and comprises multiple hypervariable regions that vary in sequence between species and that are flanked by highly con served regions 46 . These conserved regions allow the 16S rRNA gene to be targeted by primers for broad PCRbased amplification of the bacterial DNA present in a sample, whereas sequence variation in the targeted hypervariable region enables taxonomic identification of the bacteria. Importantly, as the degree of variation in the 16S rRNA gene of samples functions as an evolu tionary chronometer, their similarity (or dissimilarity) also reveals the degree of relatedness of particular taxa, which might also offer insight into shared biological properties 47 . Most 16S rRNA gene sequencing studies target a specific hypervariable region, or a set of adjacent hypervariable regions, which typically allows for taxo nomic identification down to the genus level. Notably, as 16S rRNA sequencing cannot discriminate between DNA from viable and nonviable bacteria, most micro biome analyses are a snapshot of both the living and dead microbiota.
Additional methods for investigating microbiota include expanded quantitative urine culture (EQUC), which uses a variety of culture media and incubation conditions to cultivate bacteria that do not grow under standard culturing conditions 4, 9, 48 , and quantitative PCR (qPCR), which provides a targeted approach to quan tify specific bacterial DNA 49 . Although certainly useful, EQUC and qPCR might require a priori knowledge of the physiological or DNA sequence properties of con stituent bacteria in a sample and are, therefore, inher ently selective. The remainder of this Review focuses on the major steps involved in microbial community profiling using 16S rRNA gene sequencing given that this technique is less intrinsically biased than the afore mentioned alternative methods and is currently the most widely adopted method for studying complex microbial communities. These steps include bacterial DNA extrac tion, PCR amplification of the 16S rRNA gene and DNA sequencing (Fig. 1) .
DNA extraction
DNA extraction from bacteria involves two major steps -cell lysis and DNA purification 50 . In the first step, the cell membrane is chemically lysed using deter gents and surfactants; heat and/or mechanical lysis (for example, bead beating) can expedite this process and is often used for complex or fibrous sample types, such as stool 51 . In addition, proteases and RNases can be used to break down proteins and RNA, respectively, to improve DNA yield and limit contamination from nonDNA cellular components 52, 53 . In the second step, DNA is purified from cellular debris, salts, proteins and other remaining cellular contaminants in addition to rea gents used for cell lysis (for example, salts). DNA puri fication techniques include precipitation using either ethanol or isopropanol; phenol-chloroform extrac tion, in which aqueousphase DNA is separated from phenoldenatured proteins that segregate to a distinct organic phase; or DNA adsorption to a solid phase (for example, silica) minicolumn, in which DNA binding is modified by altering the pH and salt concentration 54 . The DNA extraction technique that is chosen will considerably affect how faithfully the extracted DNA represents the bacterial composition of the original sample. Some bacteria, such as Grampositive bacte ria and mycobacteria, might be more difficult to lyse than others in a microbial community owing to the thickness of their cell wall and, therefore, can become underrepresented in an extracted DNA sample 55 . Conversely, if the DNA extraction method is too harsh (for example, vigorous bead beating or sonication), the DNA isolated from bacterial species that are easily lysed might become sheared 55 . Currently, no standard tech nique exists that works equally well for lysing all types of bacteria in a given sample 56 , although methods involv ing bead beating and/or mutanolysin (a lytic enzyme from Streptomyces globisporus) are recommended to effectively lyse cells 55, 57 . Future studies should consider comparing different DNA extraction methods to iden tify optimal approaches for bacterial DNA extraction from urine specimens, a comparison that has been per formed for a variety of other sample types with high and low microbial biomass, such as faeces 58 , cervicovaginal lavage samples 59 and marine biofilms 60 . Although comprehensive studies investigating opti mal methods for bacterial DNA extraction from urine have not been performed, some common practices exist among researchers studying the urinary micro biota. Similar to other highvolume, low microbial bio mass samples (such as air particulates 61 and sea water or glacial ice 62 ), microorganisms within a urine sample are typically concentrated using filtration and/or cen trifugation before DNA extraction. After concentration, the DNeasy Blood and Tissue Kit (Qiagen) has been successfully used for urinary microbiome studies 4, 6, 8, 11 .
PCR amplification
The use of a marker gene such as the 16S rRNA gene for community profiling of microbiota increases the efficiency of sequencing efforts but at the cost of intro ducing multiple sources of variability during PCR amplification, which is required to generate ampli cons for sequencing. Examples include the fidelity of DNA polymerases (each of which has a distinct error profile), the quantity of the input DNA (too little or too much DNA might inhibit a PCR), the PCR cycle number (a high number of PCR cycles substantially increases the probability of amplifying contaminant DNA molecules), the choice of primers (which might bias amplification efficiencies towards some microbial species over others) and other PCR conditions (for example, reagent concentrations and PCR annealing temperature) 63, 64 . In addition, chimeric sequences might arise during PCR amplification (Fig. 2a) . The probability of generating chimaeras increases with the number of PCR cycles used 63 , and these chimeric sequences need to be removed bioinformatically.
Another major consideration is the choice of hyper variable region in the 16S rRNA gene that is targeted by the PCR primers 65, 66 . Given that no individual hyper variable region will universally distinguish all bacte rial species, targeting different hypervariable regions will result in different biases in the analysis 66 . To date, a comprehensive, systematic comparison of how well different hypervariable regions capture the diversity and composition of the urinary microbiota has not been performed. However, a variety of hypervariable regions have been used to study the urinary microbiota, including the V4 hypervariable region 9, 11, 34 , as well as the V1-V3 (reFs
), V1-V2 (reF.
67
) and V6 hypervariable regions 6, 8 . The choice of hypervariable region is particu larly important for taxonomic identification and might lead to the underrepresentation or overrepresentation of certain microbial taxa 68 in addition to limiting the resolution of the taxonomic identification that can be achieved 69 . This limitation has also been observed for different PCR conditions, such as the annealing tem perature 70 , in addition to the degree of primer degener acy (when a mixture of primers with distinct base pair substitutions is used to bind DNA regions with varia ble target sequences) 71 . Although a direct comparison of the fidelity of representation achieved by primers targeted to different hypervariable regions has yet to be performed for urine samples, the V1 (reF. 72 ) and V6
(reF.
68 ) hypervariable regions have been reported to be inferior to other hypervariable regions. Our group currently favours the V4 hypervariable region, which is also used by the Earth Microbiome Project, the most comprehensive effort to characterize thousands of sam ples from a large diversity of sample types to date 73, 74 , or the V1-V3 hypervariable region, which has been used by the Vaginal Human Microbiome Project 75 . distinct DNA sequences anneal to form a new non-biological sequence that is subsequently amplified) occur during PCR amplification, with an increased probability as the number of PCR cycles performed increases. These errors can be corrected in the bioinformatics processing workflow. b | DNA sequencing errors (including base substitutions, insertions and/or deletions) arise from incorrect base calling during sequencing and can be corrected when sequence reads are processed with platform-specific algorithms. c | Contaminant errors arise from the introduction of foreign bacteria to the sample during sample collection and sample preparation for sequencing. The identification and removal of contaminant sequences is a particular challenge for samples with low microbial biomass because the foreign bacteria can constitute a large proportion of the sample. rRNA , ribosomal RNA.
DNA sequencing

Chimeric sequences
DNA sequences that arise during PCr amplification when two distinct DNA sequences anneal to form a new, non-biological sequence, which is subsequently amplified.
pyrosequencing
A sequencing-by-synthesis DNA sequencing method based on pyrosequencing technology.
HiSeq
An illumina sequencing platform that (in high-throughput mode) has eight independent lanes (each optimally clustering at 280 million templates per lane) and read lengths up to 125 bp.
MiSeq
An illumina sequencing platform that has a dual-lane (single-sample) configuration with lower output (~20-25 million single reads (raw)) but longer read length (up to 300 bp) than Hiseq.
as the Ion Torrent (Thermo Fisher Scientific), PacBio (Pacific Biosciences) and MinION (Oxford Nanopore Technologies) sequencers.
The accuracy of sequencebased microbial profiling is highly dependent on the quality and preprocessing of the sequencing data. Sequencing errors -which origi nate from the NGS technologies and result in incorrect base calls in the output sequences (Fig. 2b) -make it difficult to distinguish technical variability from bio logical variability 76, 77 and lead to inflated measures of microbial diversity 78, 79 and incorrect taxonomic clas sification 79 ; thus, they can skew downstream analyses. The unique challenges and importance of correct ing sequencing errors in 16S rRNA gene sequencing data 80, 81 have prompted the development of bioinfor matic tools specifically for 16S rRNA gene sequencing data. Sequencing errors, and the approaches to correct them, are dependent on the specific sequencing technol ogy that is used. Most 16S rRNA gene sequence correc tion tools were developed for use with pyrosequencing technology, which is characterized by insertions, dele tions and homopolymers (stretches of identical nucleo tides) 82 , and are not applicable to Illumina sequencing data, in which errors are primarily substitution miscalls (for example, an A is called instead of a C) and are not randomly distributed 81 . Using two to three sequencing replicates can enable the identification and removal of spurious errors and has been used in sequencebased urinary microbiome studies 5, 9, 35 . Other commonly used approaches for correcting Illumina sequencing errors are quality trimming and merging overlapping pairedend reads 81 ; however, more sophisticated algorithms, such as Illuminaspecific denoising algorithms 83, 84 , are under development and in current use.
Handling contamination
In contrast to other humanassociated microbial com munities, urine -particularly cathetercollected urine -typically has a low microbial biomass. Thus, the true signal arising from sequencingbased community pro filing of the resident urinary microbiota can easily be overshadowed by signals resulting from technical vari ation and experimental errors. The accuracy of micro bial profiling in low microbial biomass samples is highly dependent on the appropriate identification, control and correction of these errors. In addition to the aforemen tioned sources of error arising from PCR amplification (chimaeras) and NGS (sequencing errors), a key con sideration for the accurate representation of a microbial community is the exposure of urine (or other) samples to environmental (or 'foreign') nucleic acids during sample collection, DNA extraction or PCR amplifica tion. This factor is most relevant for samples with low microbial biomass (Fig. 2c) .
Sources of contaminants
Sources of foreign nucleic acids include patients, healthcare staff, laboratory personnel, airborne bac teria, surface contaminants on laboratory instruments and plasticware (for example, on PCR tube lids), mol ec ular biology reagents and crosssample contamination. Indeed, the presence of contaminating DNA is reportedly widespread in commercially available DNA extraction kits and might be a major source of error in the com munity profiling of microbial samples 76, 85, 86 . Moreover, batchtobatch variation in otherwise identical DNA extraction kits can produce distinct contamination pro files 76 , and one study reported that a DNA extraction kit itself could generate >20,000 reads using Illumina MiSeq from dozens of bacterial genera 86 . Taken together, con taminant DNA can be difficult to identify and is a major problem for low microbial biomass samples.
Control of contamination
Some level of DNA contamination from sources within the laboratory should be anticipated in studies involving urine or other low microbial biomass sam ples. Unfortunately, little consensus exists on the best approach to mitigate contamination of microbiome samples with exogenous bacterial DNA, and no stand ard technique to remove these contaminants has been developed to date. Nonetheless, steps can be taken to minimize the amount of exogenous DNA that is intro duced during sample processing. One approach is the use of pretreating reagents such as ethidium mono azide followed by photoactivation to remove bacterial DNA from PCR mixes, water and other reagents [86] [87] [88] . Another approach is to use DNA extraction kits that are designed specifically to minimize contamination. However, one study has shown that techniques involv ing pretreating reagents were technically difficult and inefficient in removing background contaminants from blood and submucosal microbiome samples 86 , suggest ing that these techniques are not suitable for low micro bial biomass samples. Analytical approaches have also been developed to identify and remove contaminants from low microbial biomass samples by exploiting the correlative relationship between the abundance of individual bacteria and each sample's overall bacterial DNA concentration 78, 89 . If the contaminant sources are adequately defined, another potential analytical approach for identifying contamination is the use of SourceTracker 90 , a Bayesian approach that estimates the proportion of contaminants in a microbial com munity 91 . Further studies investigating which of these approaches are suitable for the removal of contaminant DNA sequences before identification of the urinary microbiota are needed.
Some investigators have developed lists of common bacterial genera and species that have been identified as laboratory contaminants 76, 86 . Although such lists are useful, care should be taken in how this information is handled during analysis as some of these identified con taminants might actually be biologically meaningful in a sample of interest, such as the genus Escherichia, which is a common laboratory contaminant 76, 86 but is also present in the gut microbiome 92 . Thus, researchers should not simply disregard and remove all sequences mapping to bacteria in these lists but should instead carefully mon itor any results that include these bacteria and evaluate whether the result is most likely of biological relevance or a technical artefact.
Finally, not all DNA contaminants arise from lab oratory reagents and kits. For instance, crosssample NATuRe RevIewS | UROlOgy
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Quality trimming
A data processing procedure in which low-quality sections of sequenced reads are removed.
Denoising algorithms
Algorithms that attempt to resolve errors introduced by the DNA sequencer.
contamination can easily occur between PCR tubes, plate covers and pipette tips. This mode of contamina tion is a particular issue for amplified DNA samples; therefore, the experimental steps before and after PCR amplification should be performed in dedicated labora tory spaces that have their own equipment. Extra care should be taken to avoid crosscontamination between low and high microbial biomass samples; for example, researchers should not process high and low microbial biomass samples at the same time.
Positive and negative controls
The use of both positive and negative controls is essen tial for evaluating the urinary microbiome or similar low microbial biomass samples. Negative controls can aid in the identification of contaminants that are potentially introduced during laboratory processing and enable the identification of samples that contain only contaminant DNA and that should not be used for downstream analyses. Ideally, negative controls should be subject to every step of the DNA extraction procedure, should be run in parallel with experimen tal samples and should incorporate the original sample collection materials (such as a 'clean' swab or a rinse of sample collection materials).
In addition to negative controls, positive controls are also necessary to verify that the experimental pro cedures have worked as expected. A positive control can consist of a single known bacterial isolate or a mock community with a known polymicrobial profile. Mock communities can be created by mixing known proportions of pure cultures or can be purchased com mercially. As the microbial community composition is known, the biases and accuracy of the experimen tal and computational procedure can be evaluated 80 ; in addition, the contaminants derived from the lab oratory methods used for sample preparation can be identified.
Computational considerations NGS generates millions of sequence reads that require processing before downstream analysis in order to generate information about the microbial community of interest. Accordingly, many bioinfor matics methods and tools have been developed to process these raw sequence reads. Individual bioin formatics tools are typically combined to form a bio informatics pipeline, in which the input is the raw sequence reads and the output is a data table contain ing the counts of identified bacteria (for example, an operational taxonomic unit (OTU) table) that can be used for downstream statistical analyses (Fig. 3) . The exact workflow that is selected depends on the sequencing technology employed, the format of the data received from the sequencing facility, the experimental design and the available computational resources. Developing a bioinformatics workflow for 16S rRNA gene sequence processing is important, but challenging, in large part because new software is continuously emerging and each processing step presents multiple decision points.
Researchers studying the urinary microbiome should have an understanding of the key steps involved in the processing and analysis of 16S rRNA gene sequencing data, the bioinformatics methods that have been used for data processing in previous urinary microbiome studies (TABle 1) and current areas of development that should be considered for future studies. Notably, these steps are applicable to sequencing data derived from a diversity of sample types, including urine, vaginal swabs and faeces.
Software packages and documentation
Several bioinformatics workflow software packages are currently available to implement the bioinformat ics steps involved in the processing and analysis of 16S rRNA gene sequencing data, such as OTU clus tering or amplicon sequence variant (ASV) identifica tion, chimaera removal and taxonomy assignment. Of these, Quantitative Insights Into Microbial Ecology (QIIME) 93 and mothur 94 are commonly used, includ ing in urinary microbiome studies (TABle 1) . Additional bioinformatics workflow software packages for 16S rRNA gene sequencing data exist 95, 96 . These software packages enable users to create customized workflows without requiring a deep knowledge of the intricacies of each individual step in data processing and analysis. Furthermore, they can minimize problems that might arise when the input and output formats differ between individual bioinformatics tools within a workflow. QIIME and mothur are well documented and are sup ported through online communities, which are excel lent resources for learning about the necessary steps in data processing and for troubleshooting when technical issues occur.
Importantly, when using bioinformatics workflow software packages such as QIIME or mothur, research ers should cite the package in addition to the specific methods and/or algorithms that were used within the package. Documentation of the specific details of the bioinformatics workflow (including the method, version and parameters used for each tool) is essential to ensure the fidelity of bioinformatics processing and to promote analytical transparency and reproducibility in the uri nary microbiome research field. Multiple options exist to support the documentation and sharing of data analy sis workflows. Mothur users should generate a batch file to document each generated workflow. QIIME users can create Jupyter Notebooks to document the workflow and record key outputs or summaries. Additionally, if downstream analyses are completed in the statistical programming package R, R Markdown can be used to enable the sharing of key outputs and underlying code for analyses.
Preprocessing and signal extraction
The first step in analysing raw 16S rRNA gene sequence reads is the preprocessing of the sequencing data to the format required for subsequent processing steps. This step commonly includes demultiplexing of the sequence reads if the samples are multiplexed (a common prac tice in which multiple microbiome samples are com bined on a single sequencing run) 97 and removal of the barcode and primer sequences. Preprocessing also includes quality filtering of the sequences to avoid 
Amplicon sequence variant
(AsV). groups of error-resolved DNA sequences that can be used in place of operational taxonomic units (oTUs) for analysis. Also referred to as exact sequence variants or sub-oTUs.
Demultiplexing
Ungrouping reads from a sequencing run so that reads are associated with specific samples.
Quality filtering
removing reads that contain errors above a user-defined threshold.
bias and minimize artefacts caused by PCR ampli fication and sequencing 98 (Fig. 3) . Lowquality reads are typically removed on the basis of quality scores, the presence of ambiguous bases, expected errors, mismatched bases in the barcodes and primers and sequence length 99 . When sequencing produces over lapping pairedend reads, they can be merged before quality filtering, taking advantage of redundant base NATuRe RevIewS | UROlOgy reads and through quality filtering to remove low-quality sequences, although the order of these two steps depends on the requirements of the downstream algorithms used. b | The sequence reads that pass the preprocessing step are then grouped into operational taxonomic units (OTUs) or amplicon sequence variants (ASVs). Chimeric sequences are then identified and removed. c | The resulting data table of OTU or ASV counts per sample is annotated with taxonomic assignments. d | The OTU or ASV table is used for downstream analysis to describe and understand the microbial communities. Common analyses and visualizations include alpha diversity measures to assess the richness (Chao1 estimator) and evenness (Pielou index), or both richness and evenness (Simpson index and Shannon index) of individual samples; beta diversity (non-phylogenetic Bray-Curtis distance and phylogenetic UniFrac distance) to evaluate between-sample diversity , which is typically visualized on a principal coordinate analysis or non-metric multidimensional scaling plot; and differential abundance testing to identify individual bacteria that are different between experimental groups.
calls at overlapping nucleotide positions to generate improved posterior quality scores. Although this process reduces the error rate by removing sequences of poor quality and low abundance, a more rigorous and com plementary solution is to actively resolve sequencing errors using ASV algorithms that correct sequences, enabling more data to be retained for downstream analyses. The use of such algorithms is an active area of research, and new computational approaches to infer and correct Illumina sequencing errors are currently under development.
OTU clustering. Commonly, 16S rRNA gene sequenc ing workflows use OTU clustering methods to group sequences according to their similarity, the primary purpose of which being to reduce the intensiveness of downstream computations and minimize noise (Fig. 3) . The choice of clustering method and similarity threshold substantially influence downstream results
100
, and a similarity threshold of 97% is commonly used in general 100 . Most OTU clustering algorithms can be grouped into three categories -de novo, closed ref erence and open reference 101 . De novo approaches are datadriven methods that perform clustering on the basis of the similarity of sequences in the data set to one another 100, 102 . Closedreference methods cluster sequences on the basis of similarity to a reference data base 101 ; therefore, results will depend on the database that is used. This caveat is problematic for the micro bial profiling of urine samples and other understudied environments given that few of the constituent bacte ria in these samples might be represented in existing reference databases. Finally, openreference methods first perform closedreference OTU clustering and then perform de novo OTU clustering on the sequences that failed to cluster using the reference database 101, 103 . Although all of the urinary microbiome studies pub lished to date have used OTU clustering (TABle 1) , www.nature.com/nrurol a 'Unspecified' is indicated when the specific method was not mentioned in the methods section of the manuscript. METAGENassist 136 is a comprehensive web server for comparative metagenomics. The bioinformatics methods will vary according to the sequencing unit; platform used; for example, the chimaera method Bellerophon 85 is used on Sanger sequences but is not used on short reads produced by Illumina sequencing technologies.
Posterior quality scores
scores from the sequencer that indicate the probability of an individual nucleotide being correctly called. a major limitation of these methods is that they tend to overestimate the number of bacteria that are pres ent in a sample, typically identifying thousands of unique OTUs from mock communities that have <100 true OTUs present 102, 104 . This phenomenon can lead to the incorrect determination of ecological diversity in microbiota samples obtained from the bladder, urinary tract or any other tissue site.
Alternatives to OTU clustering. A number of alternative approaches to OTU clustering -which we refer to as ASV methods -that attempt to achieve finer taxonomic resolution than traditional OTU clustering methods have been developed. These methods consider the fre quency distribution of sequences and might attempt to identify and resolve Illumina sequencing errors. Some ASV algorithms such as UNOISE2 (reF.
105
) and Deblur 106 use a priori models of sequencer error profiles, whereas DADA2 (reF.
84
) uses experimentspecific adaptive error models that are estimated from the data, and MED 107 uses information theory to distinguish closely related taxa. Once the sequencing errors have been estimated and corrected, or removed, the DNA sequence varia tion can be considered to be biologically meaningful 104 . Thus, in addition to removing noise, ASV methods offer finer taxonomic resolution than is possible with traditional OTU clustering methods 104 . Accordingly, notable benefits of ASV methods compared with OTU clustering methods include more accurate estimation of microbial diversity, given that closely related bacte rial taxa that might be grouped into a single entity by OTU clustering methods could be more successfully distinguished as ASVs 84, 104, 107 and the fact that ASV methods avoid assigning sequence variants that arise owing to error into distinct clusters 84, 105, 106 . Additional ben efits are that ASVs are more reproducible and reusable across studies and are independent of reference data bases 104 . These benefits might be particularly useful for urinary microbiome studies because the fine resolution could help distinguish true bacterial DNA sequences from contaminants to a better degree than OTU clustering methods.
Chimaera removal. The removal of chimeric sequen ces is essential for the 16S rRNA gene sequencingbased profiling of any sample but is particularly crucial for lowbiomass samples such as urine given that the number of PCR cycles required for sufficient DNA amplification is usually high, which has been shown to substantially increase the formation of chimaeras 63 ( Fig. 3) . Failure to remove chimaeras can lead to errors such as inflated diversity and the incorrect identification of novel taxa 108 . Chimaera removal algorithms can be databasedependent (that is, reliant on a reference data base of known sequences), which again might be prob lematic for urine samples owing to poor representation of constituent microbiota in the reference databases, or databaseindependent (that is, reliant on the sequences in the data set). Com monly used algorithms include ChimaeraSlayer 108 , Perseus 109 and UCHIME 110 , which are included in the bioinformatics workflow packages QIIME and mothur (TABle 1) .
Taxonomy assignment
After sequences have been grouped into OTUs or ASVs, the representative sequences must be assigned a taxon omy to identify the microorganisms that are present in the samples (Fig. 3) . In addition to choosing the appropriate database for taxonomy assignment, various algorithms exist for assigning taxonomy to individual sequence clusters, many of which are implemented in different bioinformatics workflow packages. Most methods use either a k-mer matching approach, such as the Ribosomal Database Project (RDP) Classifier 111 , or sequence match ing on the basis of similarity to a reference database using algorithms such as BLAST 112 or uclust 113 . Taxonomy assignment is also a current area of active research and improved classifiers (such as the BLCA algorithm 114 ) are under development to increase the resolution of taxonomic classification down to the species level.
The reference database is just as crucial as the algo rithm for taxonomy assignment as it will bias down stream results and must be taken into account when comparing results from different studies. Currently, three major databases are commonly used -SILVA 115 , RDP 116 and Greengenes
117
. All of these databases include taxonomic classifications based on 16S rRNA gene sequences but take different approaches for obtaining the names of associated organisms. Both SILVA and RDP have taxonomy resolution down to the genus level and, additionally, contain information about additional marker genes (for example, 18S rRNA, 28S rRNA and ITS for identification of eukaryotic microorganisms such as fungi and largesubunit rRNAs). Greengenes is currently limited to 16S rRNA sequences but contains some taxonomy down to the species level.
Several versions of each database are available to incorporate the generation of new information. Importantly, the latest version should be used for tax onomy assignment, when possible. SILVA was updated in December 2017 and RDP was updated in September 2016, but Greengenes, although widely used, has not been updated since 2013. Although studies have not specifi cally assessed database performance for urinary micro biome profiling, SILVA is currently the most frequently used database (TABle 1) .
Body sitespecific taxonomic databases can overcome some of the limitations of general databases. Microbial sitespecific and handcurated databases have been created, including those that are specific to the vaginal microbiome 75 (optimized for the V1-V3 region of the 16S rRNA gene), the oral microbiome 118 and the gut microbiome 119 . The creation of such databases is par ticularly important for microbial niches that are poorly represented in the currently available databases or in cases in which specieslevel resolution is expected to be of importance, such as in the urinary microbiome. The cultured isolates from the bladder microbiota seem to be distinct from vaginal microbiota 120 , which supports the need for a urinary microbiome 16S rRNA database.
Downstream data analysis
Following completion of the aforementioned steps in preprocessing, signal extraction and taxonomic annota tion, the processed 16S rRNA gene sequencing data take NATuRe RevIewS | UROlOgy the form of a large data matrix, in which the columns typically represent individual samples and the rows con tain the bacterial features at the taxonomic level of inter est (phylum, class, order, family, genus or OTU and/or ASV). Each cell in the matrix indicates the number of reads identified for a given bacterial feature and sample. Several characteristics of these data make downstream statistical analysis challenging. One issue is that varia tion exists in the total number of sequences obtained per sample (referred to as the library size), which can vary by orders of magnitude. For Illumina MiSeq and HiSeq data, the number of sequences per sample can range from tens of thousands to millions of sequences, and 454 pyrosequencing data can range can from hun dreds to tens of thousands of sequences per sample 97 . The variation in the number of reads per sample does not necessarily reflect biological information but can be caused by technical variation. Normalization attempts to correct the distribution of the data and minimize the effects of uneven sampling depth on downstream analy sis (Fig. 3) . Many different normalization strategies have been proposed for 16S rRNA gene sequencing data [121] [122] [123] , but no universally accepted approach exists and the appropriate normalization will depend on the proper ties of the data and well as the types of analysis planned. Another technical challenge is the sparseness of the data matrix. Owing to the heterogeneity of the human microbiome, many cells of the full data matrix will con tain zeros (which represent unobserved data points that can be representative of actual zeros or indicative of an undersampled environment), particularly at lower tax onomic rankings (at the genus, OTU or ASV level). This sparseness can cause problems when attempting to apply certain statistical analyses, such as violating assumptions or weakening power.
Identification of community structure and diversity.
The microbial communities within a given sample are commonly described by measures of alpha diversity and beta diversity. Alpha diversity describes the withinsample diversity by taking into account how many different types of bacteria are present in a sample (richness; commonly measured with the Chao1 estima tor) and the distribution of these bacteria (evenness; commonly measured with the Pielou index). Many pop ular alpha diversity metrics, such as the inverse Simpson index and Shannon index, account for both the richness and evenness of a sample 124 . Measures of beta diversity, which refers to betweensample diversity and describes how individual samples relate to each other, are based on a distance or dissimilarity matrix that is usually calcu lated by the BrayCurtis method 125 (nonphylogenetic) or UniFrac method 126 (phylogenetic) and might account for information on the abundance of bacteria (weighted methods) or simply the presence or absence of bacteria (unweighted methods). Beta diversity is usually visual ized with a principal coordinate analysis (PCoA) plot or nonmetric multidimensional scaling (NMDS) plot, which are data reduction methods that summarize the multidimensional data to a new set of axes to represent the data in lowdimensional space 127 . Such methods pro vide a concise overview of the data set and can be used to identify whether any covariates (for example, age, BMI and menopausal status) are contributing to microbial composition (Fig. 3) .
Identification of differentially abundant bacteria.
A common goal of microbiome studies is to iden tify bacteria that are differentially abundant between groups of individuals (for example, between women with UUI and women without UUI) to identify whether specific bacteria are associated with a disease or phe notype (Fig. 3) . Following the terminology of other omics fields, this process is referred to as differential abundance testing 121, 123 . As 16S rRNA gene sequencing data are complex and do not follow a normal distribution, many studies have used nonparametric tests such as the Kruskal-Wallis rank sum or Wilcoxon rank sum tests to identify sta tistically significant differences between groups 128 . Although these approaches do not require the data to have a normal distribution, they do assume that the data have identical distributions and, therefore, will lead to erroneous conclusions if the compared data have dif ferent distributions or unequal variances. In addition, the use of these nonparametric tests in cases in which an appropriate parametric statistical test could be used might result in a loss of power to detect differences. Over the past 4 years, methods based on generalized linear models have been developed for the identifica tion of differentially abundant bacteria between groups. Some of these methods, such as DESeq2 (reF. 129 ), have been adapted from approaches to identify differential expression from RNA sequencing (RNAseq) data and repurposed to identify differentially abundant bacteria from 16S rRNA gene sequencing data. Additional meth ods such as ANCOM 130 and metgenomeSeq 123 have been specifically developed for microbiome analyses. These new methods hold promise and are growing in popu larity. However, statistical expertise is needed for their appropriate use.
Limitations of sequencing studies
Identification of the individual microorganisms and the structure of a microbial community is an important first step in understanding a previously uncharacterized microbial environment. However, additional studies must be conducted to elucidate the complex biology of humanassociated microbial communities, such as those of the urinary tract. 16S rRNA gene sequenc ing is one popular approach to profile the microbiota of an environment, but it has limitations, such as its semiquantitative nature and the aforementioned biases that are introduced through sample and data process ing. Another limitation of using sequencingbased approaches to understand humanassociated microbial communities is that they yield information only on the microbial DNA present in a sample. Although this infor mation enables the identification of the types of bacteria present in a biological sample, it does not distinguish between living and dead bacteria. The use of comple mentary techniques such as EQUC can identify live bac teria, although some bacterial species that are difficult to culture under EQUC conditions might be missed.
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Furthermore, currently used 16S rRNA gene sequencingbased approaches usually lack taxonomic resolution down to the species or strain level and do not provide information on the functional capabilities of the bacteria that are present, which could offer insight into how they contribute to host health or disease. Functional microbial community profiling by shotgun metagenom ics, transcriptomics, proteomics and metabolomics can provide novel insights into the biological functionality of microbial communities and, therefore, should also be pur sued in tandem with 16S rRNA gene sequencingbased community profiling, if possible 22 . This approach could provide the opportunity to refine and validate community profiles by testing for linkage of observed commu nity members to functional states of the community and urinary mucosa, as has been applied for intestinal microbiome analysis in hepatic metabolic disease 131 , type 2 diabetes mellitus 132 and Crohn's disease 133 . Finally, although bacteria isolated from catheter collected urine specimens are considered to be a reflec tion of the microbiota that reside in the bladder, sampling of the microbiota from urine might not enable the detec tion of all bladderresident microorganisms. Indeed, the differences between the urinary microbiota and the urotheliumassociated microbiota of the bladder are currently unknown. Given that the mucosaassociated microbiota of the intestinal tract are distinct from those found in stool 134, 135 , such sitespecific differences proba bly exist in the bladder, and the elucidation of these dif ferences will probably require sampling procedures that are more invasive than cathetercollected or cleancatch midstream urine sampling methods, such as biopsies or lavages.
Conclusions
The clinical relevance of the urinary and genitourinary microbiota in health and disease is now only just begin ning to be understood 120 . Since the discovery of the genitourinary microbiota in 2010 (reF. 13 ) and urinary microbiota in 2012 (reF. 1 ), several studies have con firmed that most adults harbour microbial communi ties in their lower urinary tracts 6, 7, 13 , and many women have microorganisms in their bladders 2, 3 . Furthermore, these microorganisms have been shown to be alive and cultivatable under nonstandard culturing conditions 6, 20 . The urinary microbiota seem to be altered between women with and without bladder disorders such as UUI 4, 5, 9, 11 , and the composition of these microbial communities has also been associated with the successful treatment of UUI 35 and the risk of infection after treatment 5 . Furthermore, the genitourinary microbiota has been found to be altered in women with IC/BPS 8,12 compared with women without IC/BPS and in men with sexually transmitted infections 13 , prostatitis 14 , chronic pelvic pain 15, 16 and prostate cancer 17 compared with those without the disorders. These studies provide strong evi dence that the urinary microbiota is probably clinically relevant and warrants further investigation.
As the roles of the urinary and genitourinary micro biota in urinary tract disorders, as well as the potential therapeutic opportunities they present, are beginning to be elucidated, the technical and computational nuances for the profiling of low microbial biomass environments must be considered (Fig. 1) . Further research to under stand these microbial communities and their relation ship with urological disorders will require careful sample collection and data analysis to draw robust and repro ducible conclusions. Studies collecting specimens for 16S rRNA gene sequencing and analysis of the urinary microbiota should also consider banking specimens in a biobank for future use and performing additional experiments to develop an improved picture of the uri nary microbiota's role in urinary tract health and disease. This Review provides an initial framework to help shape community guidelines and maximize the potential of this emerging and highly interdisciplinary field of study.
